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There is growing evidence that serum vitamin D levels are inversely related to the 
severity of COVID-19. However, it is not yet known whether this relationship is observed 
independently of the type of variant of SARS-CoV-2 that has caused the infection or if 
this is variant-dependent. In this context, we studied a series of clinical cases with a 
positive diagnosis of COVID-19 and required hospitalization in the unit of critical care 
at a hospital from Argentina. At the time of this study, the variants of SARS-CoV-2 with 
the highest circulation in this country were the Lambda (Andina) and Gamma (Manaus) 
variants. The obtained results would indicate that the inverse relationship studied is 
evidenced, at least, against infection by the two variants mentioned. However, to deepen 
this possible relationship against other variants, additional studies should be carried 
out in populations with a different viral circulation profile.
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Introduction  
During the current pandemic of atypical pneumonia caused 
by the SARS-CoV-2 coronavirus, it has been observed that vitamin 
D (VD) deficiency would represent a significant risk factor in the 
severity and prognosis of COVID-19 with a higher prevalence of 
hypertension and cardiovascular diseases. As of August 2021, 
Argentina was the second Latin American country with the highest 
number of confirmed cases and the fifth with the highest number 
of deaths from COVID-19, according to official statistics [1], despite 
having been subjected to one of the longest quarantines of the 
 
world, which justifies and strengthens the selection of this country 
to carry out research works such as the one presented here. 
Previous studies consider that the weighted average prevalence 
of VD deficiency in the Argentine adult population is around 
43.3% [2]. In this context, the present study aimed to investigate 
the possible relationship between the evolution of the disease 
concerning serum VD levels in a series of clinical cases of patients 
with COVID-19. They were admitted to the critical care area of 
Hospital Luis Carlos Lagomaggiore, Mendoza, Argentina.
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Presentation of the Series of Clinical Cases
We present a series of 5 patients, 2 men and 3 women in an age 
range of 25 to 86 years, with a positive diagnosis by polymerase 
chain reaction (PCR) to detect SARS-CoV-2. They all required 
admission to the critical care unit due to acute respiratory 
failure and received the standard care recommended to manage 
this pathology (invasive hemodynamic monitoring, mechanical 
ventilation, and other procedures). Table 1 shows the clinical 
cases and the most outstanding variables analyzed. Biochemical/
inflammatory parameters were requested (vitamin D, D-Dimer, 
ferritin, ultrasensitive C-reactive protein, blood count, among 
others). Likewise, ventilatory mechanics measurements were 
performed at the time of linkage to mechanical ventilation (MRA). 
As observed in the series of cases presented, the serum VD levels in 
all the patients analyzed are below what is established as normal 
or sufficient levels of VD (> 30 ng/mL), reaching not only levels of 
insufficiency (<30 ng/mL), but even VD deficiency (<20 ng/mL). 
Regarding mortality, of the total sample (100%), 2 (40%) patients 
died. The deceased patients were identified as 3 and 4, and they 
also had the lowest values in the VD dosage (7.98 ng/mL and 17.3 
ng/mL, respectively).
Table 1: Variables were analyzed in the 5 patients belonging to the series of clinical cases studied. Abbreviations: acute respiratory 
distress syndrome (ARDS), HT (hypertension), BMI (body mass index), TB (smoking), DBT (diabetes), ICU (intensive care unit), PEEP 
(end-expiratory pressure), MRA (mechanical ventilation), CRP (C-reactive protein), and Mean ± SD (mean ± standard deviation of 
the 5 patients) for the quantitative variables.
Measured 
Variable Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Mean ± SD
Age 59 years 71 years 25 years 45 years 86 years 57.2±23.49
Sex Male Male Female Female Female
APACHE II 10 18 16.5 8 29 16.25±9.53
Vitamin D 22.7 24.17 7.98 17.3 20,25 18.454±6.40
(ng/mL)
Need for PRONO Yes No No Yes Yes
MRA Days 5 7 6 12 6 7.2±2.77
BMI 26 22 35 30 31 28.8±4.96

















ARDS Severity Severe Severe Severe Severe Severe ---------
PLATEAU Pressure 27 22 17 14 23 20.6±5.12
Compliance (mL/




14 12 14 12 12 12.8±1.09
Dimer D (ng/mL) 300 670 900 490 609 593.8±165.6
Ferritin (ng/dL) 245 504 120 290 324 296.6±123.8
CRP (mg/dL) 180 230 456 309 156 266.2±106.9
White Blood Cells 
(number/mm3) 4,180 5,677 12,344 10,988 6,788 5,797±3,190
Discussion
The 5 patients studied showed a significant increase in 
inflammatory parameters, accounting for the severity of the 
COVID-19 developed, starring the characteristic cytokine storm. 
Consistent with our results, some previous studies have suggested 
the existence of an inverse relationship between serum VD levels 
and the degree of severity due to COVID-19 [3-8]. However, none 
of them has specifically evaluated this relationship in patients 
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affected by the variants of SARS-CoV-2 Gamma (Manaus) and 
Lambda (Andina), with a majority presence in Argentina at the 
date of this study [9].Therefore, the importance of this research is 
fundamentally in that its results would contribute significantly to 
establish an inverse relationship between serum levels of VD and 
severity of COVID-19 in patients infected by the variants mentioned 
above, representing an essential contribution to the genomic 
surveillance process [10], not only in Argentina, if not in all those 
countries in the world that are mainly affected by the presence 
of the Lambda and Gamma variants. This contribution would 
significantly improve the prevention and treatment of COVID-19, 
mainly when any of these variants develops the infection. Likewise, 
additional studies should be performed in populations with another 
viral circulation profile to evaluate this relationship (VD levels vs 
COVID-19 severity) versus other SARS-CoV-2 variants.
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